Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction “R3” Trial): protocol and study design

BACKGROUND: Individuals with two copies of the apolipoprotein-1 (APOL1) gene risk variants are at high risk (HR) for non-diabetic kidney disease. The presence of these risk variants is highest in West Africa, specifically in Nigeria. However, there is limited availability of dialysis and kidney tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Aliyu, Muktar H., Wudil, Usman J., Ingles, Donna J., Shepherd, Bryan E., Gong, Wu, Musa, Baba M., Muhammad, Hamza, Sani, Mahmoud U., Abdu, Aliyu, Nalado, Aisha M., Atanda, Akinfenwa, Ahonkhai, Aima A., Ikizler, Talat A., Winkler, Cheryl A., Kopp, Jeffrey B., Kimmel, Paul L., Wester, C. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558910/
https://www.ncbi.nlm.nih.gov/pubmed/31182139
http://dx.doi.org/10.1186/s13063-019-3436-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558910/
https://www.ncbi.nlm.nih.gov/pubmed/31182139
http://dx.doi.org/10.1186/s13063-019-3436-y

Ejemplares similares